All Infection Prevention & Control articles – Page 8
-
NewsResearchers work toward universal flu, HIV vaccines
What if there was a way to achieve stronger, multi-year protection from a single flu jab? Researchers are looking to better understand a viral mechanism shared between influenza and HIV with the aim of disrupting infection. This research could help develop effective vaccines for both diseases, as well as new antivirals.
-
NewsResearchers warn eye infections can cause preventable vision loss
Rising rates of infectious eye diseases are increasing the risk of preventable sight loss, with researchers warning that delayed diagnosis can have lasting consequences. New reviews highlight the importance of recognising symptoms such as blurred vision, floaters and sudden visual changes early, when treatment is most effective.
-
NewsAnti-cancer molecules show promise in the fight against malaria
Molecules known for their anti-cancer activity have proven effective in combating Plasmodium falciparum, the parasite that causes malaria. Researchers also investigated how differences in the structure of these molecules affect their impact on the parasites.
-
NewsHoneybee silk could power smarter wound dressings
Recombinant honeybee silk can be bioengineered in a lab, allowing researchers to modify the protein sequence and potentially introduce new features into the materials, such as infection-sensing signals or targeted drug release.
-
NewsAPIC and SHEA Statement on reported erosion of CDC capacity
Reports that the CDC has lost nearly a third of its workforce, including experienced scientists in its emerging infectious disease and respiratory disease centers, means guidance is slower to arrive, technical assistance is harder to reach, and scientific expertise is thinner at a time when most needed, experts warn.
-
NewsAbout 1 in 3 Americans say RFK Jr. recommends measles vaccination
The number of measles cases in the United States is at the highest level in decades, attributed to a decrease in vaccination against measles. The public remains evenly divided on whether or not U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recommends the MMR vaccine.
-
NewsWHO reports latest global trends in cholera, meningitis and plague
Cholera deaths increased by 30% in 2025, despite fewer cases being reported to the World Health Organization (WHO). In 2025, 47 countries reported 451 499 cholera cases and 7870 deaths to WHO, the highest number of annual cholera deaths reported to WHO since 1999.
-
NewsScientists overcome key barrier to self-amplifying vaccines
Scientists have overcome a key barrier to self-amplifying vaccines. The innovation could enable protection at lower doses, meaning vaccines could be rolled out further and faster than was previously imaginable. saRNA vaccines hold great promise but are hindered by an inherent flaw which undermines their effectiveness.
-
NewsStudy finds community-led dog vaccination could save children’s lives
A community-based approach to vaccinating dogs against rabies could help protect countless children in Africa and other areas from one of the world’s deadliest infectious diseases, according to a new study. The new approach also maintained more consistent vaccination coverage throughout the year.
-
NewsKU secures $5.8 million NIH grant to advance infectious disease research
The National Institutes of Health awarded the University of Kansas $5.8 million for Phase 3 of KU’s Chemical Biology of Infectious Disease center, supporting researchers across KU, KU Medical Center, Kansas State, Wichita State and regional partners in addressing infectious disease and antibiotic resistance.
-
NewsA natural defence against skin-infecting fungi: Mediterranean rockrose extract
A polyphenol-rich extract from Cistus salviifolius demonstrated fungicidal activity against several dermatophytes and decreased fungal infection in a laboratory model of human epidermis.
-
NewsNew tool closes gap on untapped potential of phages
A new tool to mutate bacteriophages – viruses that infect bacteria – provides a big leap forward in both our understanding of how they function, and our ability to harness their full potential. The new method allows for genome-wide mutagenesis of bacteriophages using CRISPR-Cas technology.
-
NewsDrug helps bladder cells to clear urinary infections
Researchers have identified a way to strengthen the bladder cells’ ability to eliminate urinary tract infection bacteria sheltered in the cells of the epiithelium. The drug OM-89, marketed as Uro-Vaxom®, activates cellular degradation pathways in bladder epithelial cells while also increasing the amount of antibiotic that enters them.
-
NewsBlood test shows whether newborns with fever have bacterial or viral infection
A new study suggests a test that compares the levels of two molecules in the blood is able to accurately distinguish between bacterial and viral infections in newborn babies with fever.
-
NewsFrog’s coat of bacterial armor helps protect it from fungal disease
The bacteria living on frogs’ skin could serve a vital role in protecting the animal from a deadly fungal disease. A team of researchers found that frogs’ natural skin bacteria can help them fight disease and improve their chances of survival.
-
NewsA new mechanism of action against an old enemy
Researchers identified corramycin as a promising candidate against Mycobacterium tuberculosis. In the laboratory, the natural compound is effective against various forms of the tuberculosis pathogen, including strains from clinical samples that are already resistant to common antibiotics.
-
NewsResearchers uncover what could make some bacteria-killing viruses more effective than others
Bacteriophages — or phages, for short — are viruses that kill bacteria, and scientists have been studying them for decades as a possible solution to antibiotic-resistant infections. But phages are notoriously picky eaters — a phage that can eradicate one bacterial strain is often powerless against others, even if the ...
-
NewsResearchers use computational design to engineer immune cells to fight cancer and viruses
Researchers have used advanced computational design methods to enhance the ability of genetically engineered immune cells to recognize and attack cancer and viral targets.
-
NewsA shorter, better-tolerated treatment for chagas disease is possible
A 30-day course of benznidazole taken once a day could offer people with chronic Trypanosoma cruzi infection a safer and more practical option than the current standard treatment, taken twice a day for 60 days.
-
NewsTarget identified in treatment of neuroHIV
NeuroHIV occurs when HIV infection affects the function and structural integrity of the brain and, to some extent, the spinal cord and peripheral nervous system. New research has identified a brain protein driving this damage, pointing toward a possible treatment.